Medtronic PLC (NYSE:MDT)

127.70
BATS BZX Real-Time Price
As of Oct 15
 -0.05 / -0.04%
Today’s Change
98.94
Today|||52-Week Range
135.89
+9.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$171.9B

Company Description

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Diabetes Group segment offers insulin pumps, coninuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Contact Information

Medtronic Plc
20 On Hatch
Dublin Dublin 2
P:(531) 438-1700
Investor Relations:
(763) 505-4626

Employees

Shareholders

Mutual fund holders45.81%
Other institutional37.66%
Individual stakeholders0.17%

Top Executives

Geoffrey Straub MarthaChairman & Chief Executive Officer
Gregory L. SmithExecutive VP-Global Operations & Supply Chain
Karen L. ParkhillChief Financial Officer & Executive Vice President
Richard E. KuntzChief Medical & Scientific Officer, Senior VP
Laura MauriChief Clinical & Regulatory Officer, Senior VP